Endocytosis of cadherin from intracellular junctions is the driving force for cadherin adhesive dimer disassembly.
The adhesion receptor E-cadherin maintains cell-cell junctions by continuously forming short-lived adhesive dimers. Here mixed culture cross-linking and coimmunoprecipitation assays were used to determine the dynamics of adhesive dimer assembly. We showed that the amount of these dimers increased dramatically minutes after the inhibition of endocytosis by ATP depletion or by hypertonic sucrose. This increase was accompanied by the efficient recruitment of E-cadherin into adherens junctions. After 10 min, when the adhesive dimer amount had reached a plateau, the assembly of new dimers stalled completely. These cells, in a striking difference from the control, became unable to disintegrate both their intercellular contacts and adhesive dimers in response to calcium depletion. The same effects, but after a slightly longer time course, were obtained using acidic media, another potent approach inhibiting endocytosis. These data suggest that endocytosis is the main pathway for the dissociation of E-cadherin adhesive dimers. Its inhibition blocks the replenishment of the monomeric cadherin pool, thereby inhibiting new dimer formation. This suggestion has been corroborated by immunoelectron microscopy, which revealed cadherin-enriched coated pit-like structures in close association with adherens junctions.
Troyanovsky
Regina B
RB
Division of Dermatology, Washington University Medical School, St. Louis, MO 63110, USA.
Sokolov
Eugene P
EP
Troyanovsky
Sergey M
SM
D021581:Active Transport, Cell Nucleus; D000255:Adenosine Triphosphate / Q000172:deficiency; D022005:Adherens Junctions / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D000268:Adhesiveness / Q000187:drug effects; D015820:Cadherins / Q000737:chemistry / Q000378:metabolism* / Q000648:ultrastructure; D002118:Calcium / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism; D003432:Cross-Linking Reagents; D019281:Dimerization; D004705:Endocytosis / Q000187:drug effects; D006801:Humans; D006982:Hypertonic Solutions / Q000494:pharmacology; D007700:Kinetics; D013395:Sucrose / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D015820:Cadherins; D003432:Cross-Linking Reagents; D006982:Hypertonic Solutions; D013395:Sucrose; D000255:Adenosine Triphosphate; D002118:Calcium